质瘤患者早期术后生活质量 - 一项前性队列研究

João Meira Gonçalves1, Jorge Moutinho2, Paulo Linhares1

  • 1Department of Neurosurgery, São João (ULS São João), Porto, Portugal; Faculty of Medicine, University of Porto (FMUP), Porto, Portugal.

Neurocirugia
|December 1, 2025
PubMed
概括

手术后六个月,质瘤患者的生活质量 (QoL) 得到改善,特别是在高度质瘤 (HGG) 病例中. 整体切除与更好的QOL结果有关,挑战了以前的恶化发现.

相关概念视频

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
396
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
734
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870